cooperation, data sharing, and collaboration with states, the federal government, and local partners, including nonprofit agencies, hospitals, healthcare and medical services providers, and academia to reduce opioid abuse. (5) Evaluation and recommendation of policies and procedures for improved access and more effective opioid abuse treatment and prenatal care for pregnant women with substance abuse problems, including but not limited to clarifying current services available for these women, increasing the number of providers properly trained to provide care to this group, and effective ways to achieve treatment over incarceration. (6) Evaluation of medical professional training and the efficacy of educational materials and public education as an outreach strategy to raise public awareness about the dangers of misuse and abuse of opioid drugs. (7) Assessment of alternatives to incarceration and medical treatment of opioid-addicted individuals suffering from severe substance abuse disorders. (8) Recommendations for any appropriate changes to relevant legislation, administrative rules, or pharmaceutical prescribing to mitigate opioid abuse. The following Commission Report to the legislature encapsulates the committee’s work and the suggestions for each of the topics above. Topic 8, recommendations regarding changes to relevant legislation, “appropriate administrative rules, or pharmaceutical use to mitigate opioid abuse” works to summarize each of the topical areas to provide the Legislature with actionable suggestions. This committee recommends that the Legislature review possible legislation, administrative rules, and policy changes as listed below: Prescriber licensing boards should adopt the CDC guidelines for primary care physicians which focus on the first twelve weeks of therapy.
cooperation, data sharing, and collaboration with states, the federal government, and local partners, including nonprofit agencies, hospitals, healthcare and medical services providers, and academia to reduce opioid abuse. (5) Evaluation and recommendation of policies and procedures for improved access and more effective opioid abuse treatment and prenatal care for pregnant women with substance abuse problems, including but not limited to clarifying current services available for these women, increasing the number of providers properly trained to provide care to this group, and effective ways to achieve treatment over incarceration. (6) Evaluation of medical professional training and the efficacy of educational materials and public education as an outreach strategy to raise public awareness about the dangers of misuse and abuse of opioid drugs. (7) Assessment of alternatives to incarceration and medical treatment of opioid-addicted individuals suffering from severe substance abuse disorders. (8) Recommendations for any appropriate changes to relevant legislation, administrative rules, or pharmaceutical prescribing to mitigate opioid abuse. The following Commission Report to the legislature encapsulates the committee’s work and the suggestions for each of the topics above. Topic 8, recommendations regarding “appropriate changes to relevant legislation, administrative rules, or pharmaceutical use to mitigate opioid abuse” works to summarize each of the topical areas to provide the Legislature with actionable suggestions. This committee recommends that the Legislature review possible legislation, administrative rules, and policy changes as listed below: Prescriber licensing boards should adopt the CDC guidelines for primary care physicians which focus on the first twelve weeks of therapy.
Opioid-Commission-Report_draft-3.22.17.docx